Cytocom
Ms. Lopez is a Certified Clinical Research Coordinator, she started at the site level then moved into pharmaceutical, she brings more than twenty years experience in clinical research and management to the Cytocom team. She has coordinated over 100 phase I-IV studies in several different therapeutic areas including cardiovascular, endocrinology, gastroenterology, gynecology, immunology, infectious diseases & vaccines, neurology, ophthalmology, and urology.
Ms. Lopez attended the University of Washington and is a member of both the Association of Clinical Research Professionals and the ACRP Northwest Chapter. She has been a guest speaker representing the perspective of the clinical site on multiple platforms and is currently an active task force member for ACRP.
This person is not in any offices
Cytocom
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel second-generation immune therapies to deliver immune homeostasis based on proprietary platforms. The company has four phases 3 ready programs in Crohn’s Disease, Fibromyalgia, MS, and Pancreatic Cancer.